Publications by authors named "Viola Ghizzoni"

Claim this Profile
R
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.
Elena Giudice, Vanda Salutari, Carolina Maria Sassu, Viola Ghizzoni, Maria Vittoria Carbone

Expert Rev Anticancer Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, Vanda Salutari, Maria Vittoria Carbone, Viola Ghizzoni

Cancer Manag Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in patients with mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.
Lucia Musacchio, Serena Boccia, Claudia Marchetti, Angelo Minucci, Floriana Camarda, Viola Ghizzoni

Int J Gynecol Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.
Vanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone, Elena Giudice, Serena Cappuccio

Int J Gynecol Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress in the use of pharmacotherapy for endometrial cancer.
Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Viola Ghizzoni

Expert Opin Pharmacother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Francesca Tronconi, Camilla Nero, Elena Giudice, Vanda Salutari, Lucia Musacchio, Viola Ghizzoni

Crit Rev Oncol Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Lucia Musacchio, Daniela Califano, Michele Bartoletti, Laura Arenare, Domenica Lorusso, Viola Ghizzoni

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors Resistance: Mechanisms and Perspectives.
Elena Giudice, Marica Gentile, Vanda Salutari, Caterina Ricci, Lucia Musacchio, Viola Ghizzoni

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.
Lucia Musacchio, Carlo Maria Cicala, Vanda Salutari, Floriana Camarda, Maria Vittoria Carbone, Viola Ghizzoni

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review.
Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Viola Ghizzoni

Crit Rev Oncol Hematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).
Lucia Musacchio, Vanda Salutari, Sandro Pignata, Elena Braicu, David Cibula, Viola Ghizzoni

Int J Gynecol Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine.
Serena Cappuccio, Maria Grazia Distefano, Viola Ghizzoni, Anna Fagotti, Giovanni Scambia

Gynecol Oncol Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari, Laura Arenare, Domenica Lorusso, Viola Ghizzoni

Gynecol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New medical approaches in advanced ovarian cancer.
Giacomo Corrado, Eleonora Palluzzi, Carolina Bottoni, Antonella Pietragalla, Vanda Salutari, Viola Ghizzoni

Minerva Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients.
Flavia Sorbi, Elisabetta Projetto, Irene Turrini, Gianna Baroni, Serena Pillozzi, Viola Ghizzoni

Biomed Res Int· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Resolution of an Acquired Uterine Arteriovenous Malformation in an Elderly Primigravida.
Viola Ghizzoni, Silvia Gabbrielli, Luca Mannini, Flavia Sorbi, Irene Turrini

Am J Case Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer.
Francesco Fanfani, Giorgia Monterossi, Viola Ghizzoni, Esther D Rossi, Giorgia Dinoi

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.
Giulio Sozzi, Stefano Uccella, Roberto Berretta, Marco Petrillo, Francesco Fanfani, Viola Ghizzoni

Int J Gynecol Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Fetal Distress and Placental Damage might be Associated with High Troponin I (cTnI) Levels in Mothers.
Irene Turrini, Flavia Sorbi, Viola Ghizzoni, Luca Mannini, Massimiliano Fambrini

Am J Case Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New adverse obstetrics outcomes associated with endometriosis: a retrospective cohort study.
Luca Mannini, Flavia Sorbi, Ivo Noci, Viola Ghizzoni, Federica Perelli

Arch Gynecol Obstet· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer.
Ivo Noci, Flavia Sorbi, Luca Mannini, Elisabetta Projetto, Serena Pillozzi, Viola Ghizzoni

Front Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Vein Thrombosis Presenting as Acute Abdomen in Puerperium.
Flavia Sorbi, Luca Mannini, Martina Aldinucci, Viola Ghizzoni, Massimiliano Fambrini

J Clin Diagn Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Unscarred Uterine Rupture at 15 Weeks of Pregnancy: A Case Report.
Luca Mannini, Flavia Sorbi, Viola Ghizzoni, Giulia Masini, Massimiliano Fambrini

Ochsner J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis